(Q40458894)

English

Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.

scientific article published on 23 December 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

phase II clinical trial

0 references

author name string

Pradier O

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Lederer K

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hille A

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Weiss E

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Christiansen H

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Schmidberger H

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Hess CF

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

23 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

131

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

261-269

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

https://scigraph.springernature.com/pub.10.1007/s00432-004-0633-0

0 references

Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-004-0633-0

21 January 2018

A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of twice-weekly gemcitabine and concurrent thoracic radiation for patients with locally advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose and fractionation concepts in the primary radiotherapy of non-small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concurrent paclitaxel-cisplatin and twice-a-day irradiation in stage IIIA and IIIB NSCLC shows improvement in local control and survival with acceptable hematologic toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cumulative risk of lung cancer among current, ex- and never-smokers in European men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of the hypoxic subvolume on the survival of patients with head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted molecular mechanisms of epoetin alfa

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic options for regionally advanced non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted therapies for stage III non-small cell lung cancer: integration in the combined modality setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for stage III nonsmall cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of taxanes in the combined modality treatment of patients with locally advanced non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin and radiotherapy: a dangerous combination?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant (induction) treatment for non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan and platinums in the treatment of non small-cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the efficacy and acute toxicity of weekly versus daily chemoradiotherapy for non-small-cell lung cancer: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of daily low-dose carboplatin and thoracic radiotherapy in elderly patients with locally advanced non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15616830

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-004-0633-0

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40458894&oldid=1494009505"